Healthcare provider profile · identity verified

Devon Jack Branvold, M.D.

Internal Medicine · AUSTIN, TX · NPI 1144515321

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	434	132
Gabapentin	Gabapentin	275	74
Amlodipine Besylate	Amlodipine Besylate	262	87
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	199	32
Pantoprazole Sodium	Pantoprazole Sodium	192	65
Losartan Potassium	Losartan Potassium	156	47
Metformin Hcl	Metformin Hcl	153	44
Albuterol Sulfate Hfa	Albuterol Sulfate	138	44
Lisinopril	Lisinopril	132	41
Fluticasone Propionate	Fluticasone Propionate	126	39
Carvedilol	Carvedilol	108	30
Metformin Hcl Er	Metformin Hcl	105	32
Ozempic	Semaglutide	103	25
Jardiance	Empagliflozin	100	25
Levothyroxine Sodium	Levothyroxine Sodium	91	32
Furosemide	Furosemide	81	36
Mounjaro	Tirzepatide	74	14
Rosuvastatin Calcium	Rosuvastatin Calcium	73	31
Tizanidine Hcl	Tizanidine Hcl	72	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	24
Tamsulosin Hcl	Tamsulosin Hcl	70	26
Metoprolol Succinate	Metoprolol Succinate	68	27
Hydrochlorothiazide	Hydrochlorothiazide	62	23
Tramadol Hcl	Tramadol Hcl	61	23
Ibuprofen	Ibuprofen	60	19
Zolpidem Tartrate	Zolpidem Tartrate	60	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	14
Meloxicam	Meloxicam	59	14
Trulicity	Dulaglutide	59	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	57	18
Metoprolol Tartrate	Metoprolol Tartrate	54	18
Acetaminophen-Codeine	Acetaminophen With Codeine	53	17
Alprazolam	Alprazolam	53	suppressed
Trazodone Hcl	Trazodone Hcl	51	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	11
Mirtazapine	Mirtazapine	48	16
Diclofenac Sodium	Diclofenac Sodium	47	18
Duloxetine Hcl	Duloxetine Hcl	47	15
Naproxen	Naproxen	46	15
Eliquis	Apixaban	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	43	11
Irbesartan	Irbesartan	43	suppressed
Montelukast Sodium	Montelukast Sodium	43	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	11
Potassium Chloride	Potassium Chloride	40	13
Pravastatin Sodium	Pravastatin Sodium	40	14
Omeprazole	Omeprazole	39	14
Triamcinolone Acetonide	Triamcinolone Acetonide	38	18
Celecoxib	Celecoxib	37	12
Pregabalin	Pregabalin	37	suppressed
Glipizide Er	Glipizide	35	12
Allopurinol	Allopurinol	33	12
Clonazepam	Clonazepam	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Spironolactone	Spironolactone	29	11
Alendronate Sodium	Alendronate Sodium	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Meclizine Hcl	Meclizine Hcl	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	11
Ondansetron Odt	Ondansetron	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Diazepam	Diazepam	26	suppressed
Tresiba Flextouch U-100	Insulin Degludec	26	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	25	suppressed
Doxepin Hcl	Doxepin Hcl	25	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	25	suppressed
Mupirocin	Mupirocin	25	suppressed
Tradjenta	Linagliptin	25	suppressed
Famotidine	Famotidine	23	suppressed
Levemir Flexpen	Insulin Detemir	23	suppressed
Methocarbamol	Methocarbamol	23	12
Ciclopirox	Ciclopirox	22	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Ibandronate Sodium	Ibandronate Sodium	21	suppressed
Linzess	Linaclotide	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Torsemide	Torsemide	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	12
Baclofen	Baclofen	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Glipizide	Glipizide	19	suppressed
Sertraline Hcl	Sertraline Hcl	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Indapamide	Indapamide	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Prednisone	Prednisone	14	suppressed
Simvastatin	Simvastatin	14	suppressed
Valsartan	Valsartan	14	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Desloratadine	Desloratadine	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Atenolol	Atenolol	11	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Finasteride	Finasteride	11	suppressed
Incontrol Pen Needle	Pen Needle, Diabetic	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error